Global Plerixafor Market Growth (Status and Outlook) 2022-2028
- LP 4798518
- 61 Pages
- January 2022
- Pharmaceuticals
The United States Plerixafor market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Plerixafor market, reaching US$ million by the year 2028. As for the Europe Plerixafor landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Plerixafor players cover sanofi-aventis, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Plerixafor market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
24MG/1.2ML
Type II
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Non-Hodgkin's lymphoma (NHL) Patients
Multiple myeloma (MM) Patients
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
sanofi-aventis
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Plerixafor Market Size 2017-2028
2.1.2 Plerixafor Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Plerixafor Segment by Type
2.2.1 24MG/1.2ML
2.2.2 Type II
2.3 Plerixafor Market Size by Type
2.3.1 Plerixafor Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Plerixafor Market Size Market Share by Type (2017-2022)
2.4 Plerixafor Segment by Application
2.4.1 Non-Hodgkin's lymphoma (NHL) Patients
2.4.2 Multiple myeloma (MM) Patients
2.5 Plerixafor Market Size by Application
2.5.1 Plerixafor Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Plerixafor Market Size Market Share by Application (2017-2022)
3 Plerixafor Market Size by Player
3.1 Plerixafor Market Size Market Share by Players
3.1.1 Global Plerixafor Revenue by Players (2020-2022)
3.1.2 Global Plerixafor Revenue Market Share by Players (2020-2022)
3.2 Global Plerixafor Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Plerixafor by Regions
4.1 Plerixafor Market Size by Regions (2017-2022)
4.2 Americas Plerixafor Market Size Growth (2017-2022)
4.3 APAC Plerixafor Market Size Growth (2017-2022)
4.4 Europe Plerixafor Market Size Growth (2017-2022)
4.5 Middle East & Africa Plerixafor Market Size Growth (2017-2022)
5 Americas
5.1 Americas Plerixafor Market Size by Country (2017-2022)
5.2 Americas Plerixafor Market Size by Type (2017-2022)
5.3 Americas Plerixafor Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Plerixafor Market Size by Region (2017-2022)
6.2 APAC Plerixafor Market Size by Type (2017-2022)
6.3 APAC Plerixafor Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Plerixafor by Country (2017-2022)
7.2 Europe Plerixafor Market Size by Type (2017-2022)
7.3 Europe Plerixafor Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Plerixafor by Region (2017-2022)
8.2 Middle East & Africa Plerixafor Market Size by Type (2017-2022)
8.3 Middle East & Africa Plerixafor Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Plerixafor Market Forecast
10.1 Global Plerixafor Forecast by Regions (2023-2028)
10.1.1 Global Plerixafor Forecast by Regions (2023-2028)
10.1.2 Americas Plerixafor Forecast
10.1.3 APAC Plerixafor Forecast
10.1.4 Europe Plerixafor Forecast
10.1.5 Middle East & Africa Plerixafor Forecast
10.2 Americas Plerixafor Forecast by Country (2023-2028)
10.2.1 United States Plerixafor Market Forecast
10.2.2 Canada Plerixafor Market Forecast
10.2.3 Mexico Plerixafor Market Forecast
10.2.4 Brazil Plerixafor Market Forecast
10.3 APAC Plerixafor Forecast by Region (2023-2028)
10.3.1 China Plerixafor Market Forecast
10.3.2 Japan Plerixafor Market Forecast
10.3.3 Korea Plerixafor Market Forecast
10.3.4 Southeast Asia Plerixafor Market Forecast
10.3.5 India Plerixafor Market Forecast
10.3.6 Australia Plerixafor Market Forecast
10.4 Europe Plerixafor Forecast by Country (2023-2028)
10.4.1 Germany Plerixafor Market Forecast
10.4.2 France Plerixafor Market Forecast
10.4.3 UK Plerixafor Market Forecast
10.4.4 Italy Plerixafor Market Forecast
10.4.5 Russia Plerixafor Market Forecast
10.5 Middle East & Africa Plerixafor Forecast by Region (2023-2028)
10.5.1 Egypt Plerixafor Market Forecast
10.5.2 South Africa Plerixafor Market Forecast
10.5.3 Israel Plerixafor Market Forecast
10.5.4 Turkey Plerixafor Market Forecast
10.5.5 GCC Countries Plerixafor Market Forecast
10.6 Global Plerixafor Forecast by Type (2023-2028)
10.7 Global Plerixafor Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 sanofi-aventis
11.1.1 sanofi-aventis Company Information
11.1.2 sanofi-aventis Plerixafor Product Offered
11.1.3 sanofi-aventis Plerixafor Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 sanofi-aventis Main Business Overview
11.1.5 sanofi-aventis Latest Developments
12 Research Findings and Conclusion
Table 1. Plerixafor Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of 24MG/1.2ML
Table 3. Major Players of Type II
Table 4. Plerixafor Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Plerixafor Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Plerixafor Market Size Market Share by Type (2017-2022)
Table 7. Plerixafor Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Plerixafor Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Plerixafor Market Size Market Share by Application (2017-2022)
Table 10. Global Plerixafor Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Plerixafor Revenue Market Share by Player (2020-2022)
Table 12. Plerixafor Key Players Head office and Products Offered
Table 13. Plerixafor Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Plerixafor Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Plerixafor Market Size Market Share by Regions (2017-2022)
Table 18. Americas Plerixafor Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Plerixafor Market Size Market Share by Country (2017-2022)
Table 20. Americas Plerixafor Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Plerixafor Market Size Market Share by Type (2017-2022)
Table 22. Americas Plerixafor Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Plerixafor Market Size Market Share by Application (2017-2022)
Table 24. APAC Plerixafor Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Plerixafor Market Size Market Share by Region (2017-2022)
Table 26. APAC Plerixafor Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Plerixafor Market Size Market Share by Type (2017-2022)
Table 28. APAC Plerixafor Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Plerixafor Market Size Market Share by Application (2017-2022)
Table 30. Europe Plerixafor Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Plerixafor Market Size Market Share by Country (2017-2022)
Table 32. Europe Plerixafor Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Plerixafor Market Size Market Share by Type (2017-2022)
Table 34. Europe Plerixafor Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Plerixafor Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Plerixafor Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Plerixafor Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Plerixafor Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Plerixafor Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Plerixafor Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Plerixafor Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Plerixafor
Table 43. Key Market Challenges & Risks of Plerixafor
Table 44. Key Industry Trends of Plerixafor
Table 45. Global Plerixafor Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Plerixafor Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Plerixafor Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Plerixafor Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Plerixafor Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Plerixafor Market Size Market Share Forecast by Application (2023-2028)
Table 51. sanofi-aventis Details, Company Type, Plerixafor Area Served and Its Competitors
Table 52. sanofi-aventis Plerixafor Product Offered
Table 53. sanofi-aventis Plerixafor Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. sanofi-aventis Main Business
Table 55. sanofi-aventis Latest Developments
List of Figures
Figure 1. Plerixafor Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Plerixafor Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Plerixafor Market Size Market Share by Type in 2021
Figure 7. Plerixafor in Non-Hodgkin's lymphoma (NHL) Patients
Figure 8. Global Plerixafor Market: Non-Hodgkin's lymphoma (NHL) Patients (2017-2022) & ($ Millions)
Figure 9. Plerixafor in Multiple myeloma (MM) Patients
Figure 10. Global Plerixafor Market: Multiple myeloma (MM) Patients (2017-2022) & ($ Millions)
Figure 11. Global Plerixafor Market Size Market Share by Application in 2021
Figure 12. Global Plerixafor Revenue Market Share by Player in 2021
Figure 13. Global Plerixafor Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Plerixafor Market Size 2017-2022 ($ Millions)
Figure 15. APAC Plerixafor Market Size 2017-2022 ($ Millions)
Figure 16. Europe Plerixafor Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Plerixafor Market Size 2017-2022 ($ Millions)
Figure 18. Americas Plerixafor Value Market Share by Country in 2021
Figure 19. Americas Plerixafor Consumption Market Share by Type in 2021
Figure 20. Americas Plerixafor Market Size Market Share by Application in 2021
Figure 21. United States Plerixafor Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Plerixafor Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Plerixafor Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Plerixafor Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Plerixafor Market Size Market Share by Region in 2021
Figure 26. APAC Plerixafor Market Size Market Share by Application in 2021
Figure 27. China Plerixafor Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Plerixafor Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Plerixafor Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Plerixafor Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Plerixafor Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Plerixafor Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Plerixafor Market Size Market Share by Country in 2021
Figure 34. Europe Plerixafor Market Size Market Share by Type in 2021
Figure 35. Europe Plerixafor Market Size Market Share by Application in 2021
Figure 36. Germany Plerixafor Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Plerixafor Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Plerixafor Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Plerixafor Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Plerixafor Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Plerixafor Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Plerixafor Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Plerixafor Market Size Market Share by Application in 2021
Figure 44. Egypt Plerixafor Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Plerixafor Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Plerixafor Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Plerixafor Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Plerixafor Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Plerixafor Market Size 2023-2028 ($ Millions)
Figure 50. APAC Plerixafor Market Size 2023-2028 ($ Millions)
Figure 51. Europe Plerixafor Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Plerixafor Market Size 2023-2028 ($ Millions)
Figure 53. United States Plerixafor Market Size 2023-2028 ($ Millions)
Figure 54. Canada Plerixafor Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Plerixafor Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Plerixafor Market Size 2023-2028 ($ Millions)
Figure 57. China Plerixafor Market Size 2023-2028 ($ Millions)
Figure 58. Japan Plerixafor Market Size 2023-2028 ($ Millions)
Figure 59. Korea Plerixafor Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Plerixafor Market Size 2023-2028 ($ Millions)
Figure 61. India Plerixafor Market Size 2023-2028 ($ Millions)
Figure 62. Australia Plerixafor Market Size 2023-2028 ($ Millions)
Figure 63. Germany Plerixafor Market Size 2023-2028 ($ Millions)
Figure 64. France Plerixafor Market Size 2023-2028 ($ Millions)
Figure 65. UK Plerixafor Market Size 2023-2028 ($ Millions)
Figure 66. Italy Plerixafor Market Size 2023-2028 ($ Millions)
Figure 67. Russia Plerixafor Market Size 2023-2028 ($ Millions)
Figure 68. Spain Plerixafor Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Plerixafor Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Plerixafor Market Size 2023-2028 ($ Millions)
Figure 71. Israel Plerixafor Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Plerixafor Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Plerixafor Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
